George Hickman
Overview
Explore the profile of George Hickman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
642
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fonseca M, Mackenna B, Mehrkar A, Walters C, Hickman G, Pearson J, et al.
JMIR Public Health Surveill
. 2024 Sep;
10():e46485.
PMID: 39292500
Background: The National Health Service (NHS) Long Term Plan, published in 2019, committed to ensuring that every patient in England has the right to digital-first primary care by 2023-2024. The...
2.
Andrews C, Mathur R, Massey J, Park R, Curtis H, Hopcroft L, et al.
BMC Med
. 2024 Jul;
22(1):288.
PMID: 38987774
Background: Ethnicity is known to be an important correlate of health outcomes, particularly during the COVID-19 pandemic, where some ethnic groups were shown to be at higher risk of infection...
3.
Cunningham C, Fisher L, Wood C, Speed V, Brown A, Curtis H, et al.
BMJ Med
. 2024 May;
3(1):e000791.
PMID: 38803829
Objective: To investigate the effect of the covid-19 pandemic on the number of patients with group A streptococcal infections and related antibiotic prescriptions. Design: Retrospective cohort study in England using...
4.
Nab L, Schaffer A, Hulme W, DeVito N, Dillingham I, Wiedemann M, et al.
Pharmacoepidemiol Drug Saf
. 2024 May;
33(6):e5815.
PMID: 38783412
Electronic health records (EHRs) and other administrative health data are increasingly used in research to generate evidence on the effectiveness, safety, and utilisation of medical products and services, and to...
5.
Brown A, Fisher L, Curtis H, Wiedemann M, Hulme W, Speed V, et al.
Br J Clin Pharmacol
. 2024 Apr;
PMID: 38589944
Aims: The COVID-19 pandemic created unprecedented pressure on healthcare services. This study investigates whether disease-modifying antirheumatic drug (DMARD) safety monitoring was affected during the COVID-19 pandemic. Methods: A population-based cohort...
6.
Wood C, Speed V, Fisher L, Curtis H, Schaffer A, Walker A, et al.
Br J Clin Pharmacol
. 2024 Mar;
90(7):1600-1614.
PMID: 38531661
Aims: The COVID-19 pandemic caused significant disruption to routine activity in primary care. Medication reviews are an important primary care activity ensuring safety and appropriateness of prescribing. A disruption could...
7.
Russell M, Massey J, Roddy E, Mackenna B, Bacon S, Goldacre B, et al.
Lancet Rheumatol
. 2024 Jan;
5(10):e622-e632.
PMID: 38251486
Background: Gout is the most prevalent inflammatory arthritis, yet one of the worst managed. Our objective was to assess how the COVID-19 pandemic impacted incidence and quality of care for...
8.
Fisher L, Curtis H, Croker R, Wiedemann M, Speed V, Wood C, et al.
Elife
. 2023 Jul;
12.
PMID: 37498081
Background: The COVID-19 pandemic has had a significant impact on delivery of NHS care. We have developed the OpenSAFELY Service Restoration Observatory (SRO) to develop key measures of primary care...
9.
Tazare J, Walker A, Tomlinson L, Hickman G, Rentsch C, Williamson E, et al.
Wellcome Open Res
. 2023 Jun;
7:142.
PMID: 37362009
Patients surviving hospitalisation for COVID-19 are thought to be at high risk of cardiometabolic and pulmonary complications, but quantification of that risk is limited. We aimed to describe the overall...
10.
Fisher L, Hopcroft L, Rodgers S, Barrett J, Oliver K, Avery A, et al.
BMJ Med
. 2023 Jun;
2(1):e000392.
PMID: 37303488
Objective: To implement complex, PINCER (pharmacist led information technology intervention) prescribing indicators, on a national scale with general practice data to describe the impact of the covid-19 pandemic on safe...